Bascom Palmer eye Institute

Miami, Florida 33418

16 studies enrolling now · 94 studies all time

What they study most

AMD, Achromatopsia, Acquired Immunodeficiency Syndrome, Adenoviral Conjunctivitis, Age Related Macular Degeneration, Age-Related Macular Degeneration, Age-related Macular Degeneration, Amblyopia, Anterior Uveitis, Autosomal Dominant Optic Atrophy, Bacterial Conjunctivitis, Binocular Vision Disorder

Studies at this site

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis — Recruiting now
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis — Recruiting now
Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye — Recruiting now
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial — Recruiting now
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation — Recruiting now
Suprachoroidal Administration in Subjects With Metastases to the Choroid — Recruiting now
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye — Recruiting now
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use — Recruiting now
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma — Recruiting now
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) — Recruiting now
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene — Recruiting now
Clinical Applications of Advanced Ophthalmic Imaging — Recruiting now
EyeConic: Qualification for Cone-Optogenetics — Recruiting now
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) — Recruiting now
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) — Recruiting now
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease — Running, not enrolling
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
Global Patient Registry of Inherited Retinal Diseases — Running, not enrolling
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa — Running, not enrolling
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) — Completed
PRIMA US-Feasibility Study in Atrophic Dry AMD — Running, not enrolling
Use of the VisuMax™ Femtosecond Laser — Completed
A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease — Stopped early
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 — Stopped early
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 — Stopped early
TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study — Completed
A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US — Completed
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration — Completed
Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation — Stopped early
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) — Running, not enrolling
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases — Completed
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD — Completed
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients — Completed
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration — Completed
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy — Completed
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) — Enrolling by invitation
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA — Completed
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study — Completed
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study — Completed
Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care — Completed
Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease — APPROVED_FOR_MARKETING
Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD) — Completed
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
Anti-VEGF Treatment for Prevention of PDR/DME — Completed
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit — Completed
Single Ascending Dose Study in Participants With LCA10 — Status unconfirmed
Primary Tube Versus Trabeculectomy Study — Completed
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) — Running, not enrolling
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial) — Status unconfirmed